University of Pittsburgh PITT HOME  |  FIND PEOPLE  |  CONTACT US  
 
Health Sciences @ Pitt   |    UPMC   |    HSLS   |    School of Medicine   |    Health Sciences Calendar   |    Our News & Events  
 
HOME
ABOUT US
FACULTY
CLINICAL TRAINEES
RESEARCH TRAINEES
ATTENTION ALUMNI
RESIDENCY PROGRAM
RESIDENT WEBSITE
CONFERENCES
EVENTS
CORNEA FELLOWSHIP PROGRAM
GLAUCOMA FELLOWSHIP PROGRAM
NEURO-OPHTHALMOLOGY FELLOWSHIP PROGRAM
ORBITAL, OCULOPLASTICS AND AESTHETIC SURGERY FELLOWSHIP
PEDIATRIC OPHTHALMOLOGY FELLOWSHIP PROGRAM
RETINA FELLOWSHIP PROGRAM
CLINICAL RESOURCES
VISUAL DIAGNOSTICS, IMAGING & LASERS
OPHTHALMOLOGY RESEARCH
RESEARCH LABORATORIES
CORE RESEARCH FACILITIES
GIVING & DEVELOPMENT
LECTURE SCHEDULE
LINKS
EMPLOYMENT OPPORTUNITIES
NEWS & AWARDS
Faculty
divider bar
 
01Eller.jpg Andrew W. Eller, MD
Professor of Ophthalmology
Director, Ocular Trauma Service
Retina and Vitreous Services
University of Pittsburgh School of Medicine

Eye & Ear Institute
203 Lothrop Street
Pittsburgh, PA 15213
Phone: 412-647-2200
Email: elleraw@msx.upmc.edu
Fax: (412) 6475119
Faculty Research Interests
 
bullet point  Research Interests
a dividing bar
1984 - 1985
Coordinator, Silicone Oil
Proliferative Vitreoretinopathy Study, Eye Research Institute,
Boston, Massachusetts

1985 - 1987
Co-investigator,
Cryo-ROP Study
Co-investigator,
Evaluation of Statil in diabetic patients with peripheral symmetrical polyneuropathy

1987 - present
Co-investigator,
Cryo-ROP Follow-Up Study
The Eye & Ear Institute of Pittsburgh

1990 - present
Co-investigator,
Age Related Eye Disease Study (AREDS) The Eye & Ear Institute of
Pittsburgh

1989 - 1996
Co-investigator
Richard James Silicone Oil Study

1989-90
Co-investigator,
Study on the effect of Antihistamines in the retinal vasculature in diabetics
The Eye & Ear Institute of Pittsburgh

1989 - 1996
Co-investigator,
Efficiacy & Safety of
Tolrestat in the Treatment of Diabetic Retinopathy

1990 - 1993
Co-investigator,
Ocular Involvement in Hospitalized Patients with Candidemia

1990 - 1993
Co-investigator,
Pneumatic Retinopexy II - Clinical Trial

1991 - 1992
Principal Clinical Investigator,
Prevelance of Cataracts in Radiation Exposed Children - Chernobyl Children's Relief Fund Project

1995 - present
Co-investigator,
Merck Study for Protease Inhibitors in HIV

1996 - present
Co-investigator,
Viral Activation Transfusion Study in HIV

1996
Principle Investigator,
A randomized comparison of two dosage schedules of intravitreal ISIS 2922 for patients with advanced cytomegalovirus retinitis

1996 - present
Co-investigator,
Prophylactic Diode Laser for the Prevention of Choroidal Neovascularization in Age-Related Macular Degeneration

1998
Co-investigator,
Atrovastatin Study for Diabetic Retinopathy

1998
Co-investigator,
A 5-week, Double-Blind, Placebo-Controlled Trial of 3 Dosages of Pregabalin (75, 300, and 600 mg/day) for Treatment of Patients with Painful Diabetic Peripheral Neuropathy

1999
Co-investigator,
An 8-week Randomized, Double Blind, Placebo-Controlled, Monotherapy Trial of Pregabalin for Treatment of Chronic Low Back Pain
 
bullet point  Education
a dividing bar
Pennsylvania State University
Major: Biology
1970-1973

Pahlavi University, Medical School
Shiraz, Iran
1973-1976

Hahnemann Medical College
Philadelphia, PA
Doctor of Medicine
1976-1979

Presbyterian-University of Pennsylvania
Medical Center Philadelphia,Pennsylvania
Internship
1979-1980

Wills Eye Hospital
Department of Ophthalmology
Thomas Jefferson University
Philadelphia, Pennsylvania
Residency
1980-1983

Vitreoretinal Diseases,
Retina Associates,
Eye Research Institute of Retina
Foundation and Massachusetts Eye & Ear Infirmary
Boston, Massachusetts
Fellowship
1983-1985
 
bullet point  Academic Affiliation
a dividing bar
1997 to Present
Medical Director
UPMC Eye Care Network

1992 to Present
Associate Professor of Ophthalmology Retina & Vitreous Service
University of Pittsburgh School of Medicine
The Eye & Ear Institute of Pittsburgh
203 Lothrop Street
Pittsburgh, PA 15213

1985 - 1992
Assistant Professor of Ophthalmology
Retina & Vitreous Service
University of Pittsburgh School of Medicine
The Eye & Ear Institute of Pittsburgh
203 Lothrop Street
Pittsburgh, PA 15213

1986 - 1990
Director of Residency Training
Department of Ophthalmology
University of Pittsburgh School of Medicine
Pittsburgh, PA

1986 - present
Director of Retina Clinic
Eye & Ear Hospital of Pittsburgh
Pittsburgh, PA

1985
Chief Fellow
Retina Associates
 
bullet point  Publications
a dividing bar
Shields JA, Augsburger JJ, Bernardino V Jr, Eller AW, Kulczycki E: Melanocytoma of the Ciliary Body and Iris. Am J Ophthalmol 89: 632-635, 1980.

Larson BC, Kremer FB, Eller AW, Bernardino VB Jr: Quantitated Trauma Following Radial Keratotomy in Rabbits. Ophthalmology 90: 660-667, 1983.

Eller AW, Bernardino VB Jr: Blue Nevi of the Conjunctiva. Ophthalmology 90: 1469-1471, 1983.

Soong HK, Eller AW, Hirose T, Kenyon KR: In Situ Actin Distribution in Excised Retrolental Membranes in Retinopathy of Prematurity. Arch Ophthalmol 103: 1553-1556, 1985.

Eller AW, Jabbour NM, Hirose T, Schepens CL: Retinopathy of Prematurity. The Association of a Persistent Hyaloid Artery. Ophthalmology 94: 444-448, 1987.

Rehkopf P, Warnicki J, Friberg TF, Eller AW: Fluorescein Angiography Using Computer Image Processing Techniques. Retina 7: 246-251, 1987.

Jabbour NM, Eller AW, Hirose T, Schepens CL, Liberfarb R: Stage 5 Retinopathy of Prematurity. Prognostic Value of Morphologic Findings. Ophthalmology 94: 1640-1645, 1987.

Friberg TR, Eller AW: Pneumatic Repair of Primary and Secondary Retinal Detachments Using a Binocular Indirect Ophthalmoscope Laser Delivery System. Ophthalmology 95: 187-193, 1988.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: Preliminary Results. Arch Ophthalmol 106: 471-479, 1988.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. Multicenter trial of cryotherapy for retinopathy of prematurity: Three-Month Outcome. Arch Ophthalmology 108: 195-204, 1990.

Friberg TR, Eller AW: Serous retinal detachment resembling central serous chorioretinopathy following organ transplantation. Graefe's Arch Clin Exp Ophthalmology 228: 305-309, 1990.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. Multicenter trial of cryotherapy for retinopathy of prematurity: One-Year Outcome, Structure and Function. Arch Ophthalmol 108: 1408, 1990.

Gardner TW, Eller AW, Friberg TR: Reduction of severe macular edema in eyes with poor vision after panretinal photocoagulation for proliferative diabetic retinopathy. Graefe's Arch Clin Exp Ophthalmol 229: 323-328, 1991.

Eller AW, Friberg TR: Panretinal Photocoagulation with the Indirect Ophthalmoscope Laser System Under General Anesthesia. Ophthalmic Laser Therapy. 3 (4): 217, 1990.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. Incidence and Early Course of Retinopathy of Prematurity. Ophthalmology. 98: 1628-1640, 1991.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. The Correlation of Visual Function with Posterior Retinal Structure in Severe Retinopathy of Prematurity. Arch Ophthalmology 110: 625-631, 1992.

Eller AW, Gardner TW, D'Antonio J: Survey of Intravitreal Silicone Oil Usage in the United States. Ophthalmology. 99: 1174-1176, 1992.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. Ocular Cosmesis in Retinopathy of Prematurity. Arch Ophthalmol 110, 1992.

Friberg TR, Eller AW: Prediction of Visual Recovery After Scleral Buckling of Macula-off Retinal Detachments. Am. J. Ophthalmol. 114: 715-722, 1992.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. Prognostic Factors on the Natural Course of Retinopathy of Premataurity. Ophthalmology. 100: 230-237, 1993.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Arch Ophthalmology 111: 339-344, 1993.

Kowalski RP, Karenchak LM, Eller AW: The Role of Ciprofloxacin in Endophthalmitis Therapy. Am. J. Ophthalmol. 116 (6): 695-699, 1993

Donahue SP, Kowalski RP, Eller AW, DeVaro JM, Jewart BH: Empiric Treatment of Endophthalmitis. Are Aminoglycosides Necessary ? Arch Ophthalmology 112: 45-47, 1994.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. The Natural Ocular Outcome of Premature Birth and Retinopathy. Arch Ophthalmology 112, 903-912, 1994.

Donahue SP, Greven CM, Zoravleff JJ, Eller AW, Nguyen MH, Peacock Jr. JE, Wagener MM, Yu VL: Intraocular Candidiasis in Patients with Candidemia, Clinical Implications from a Prospective Multicenter Study. Ophthalmology. 101: 1302-1309, 1994.

Eller AW, Adams EA, Fanous MA: Anterior Chamber Maintainer for Drainage of Suprachoroidal Hemorrhage. Amer. Journal of Ophthalmology 118: 258-259, 1994.

Day R, Gorin MB, Eller AW: Prevalence of Lens Changes in Ukrainian Children Residing Around Chernobyl. Health Physics 68:632-642, 1995.

Goshorn EB, Hoover DL, Eller AW, Friberg TR, Jarrett WH2nd, Sorr EM. Subretinal Neovascularization in Children and Adolescents. Journal of Pediatric Ophthalmology and Strabismus. 32:178-82, 1995,

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. Correlation of retinopathy in fellow eyes in the cryotherapy for retinopathy of prematurity study. Arch Ophthalmology 113: 469-473, 1995.

Richard-James Silicone Oil Study Group. Silicone Oil in Repair of Retinal Detachments Caused by Necrotizing Retinitis in HIV Infection. Arch Ophthalmology 113:1401-1409, 1995.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. Early Retinal Vessel Development and Iris Vessel Dilation as Factors in Retinopathy of Prematurity. Arch Ophthalmology 114: 150-154, 1996.

Eller AW, Barad RF: Miyake analysis of anterior vitrectomy techniques. J Cataract Refractive Surgery 22:213-217, 1996.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. Visual Acuity of Eyes after Vitrectomy for Retinopathy of Prematurity: Follow-up at 5 1/2 years. Ophthalmology 103: 595-600, 1996.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. Visual Fields Measured with Double-arc Perimetry in Eyes with Threshold Retinopathy of Prematurity from the Cryotherapy for Retinoapthy of Prematurity Trial. Ophthalmology 103: 1432-1437, 1996.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. Racial Variation in Retinopathy of Prematurity. Arch Ophthalmology 115: 604-608, 1997.

Kowalski RP, Karenchak LM, Warren BB, Eller AW. Time-kill profiles of Enterococcus to antibiotics used for intravitreal therapy. Ophthalmic Surgery and Lasers 29: 295-299, 1998

Eller AW, Bontempo FA, Faruki H, Hassett AC. Peripheral retinal neovascularization associated with the Factor V Leiden mutation. Amer Journal of Ophthalmol 126:146-149, 1998.

Richard-James Silicone Oil Study Group. Azen SP, Scott IU, Flynn HW Jr. et al. Silicone Oil in the Repair of Complex Retinal Detachments, A Prospective Observational Study. Ophthalmology 105:1587-1597, 1998.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. The Incidence of Ophthalmologic Interventions in Children with Birth Weights Less Than 1251 Grams, Results Through 5 1/2 Years. Ophthalmology 105:1621-1627, 1998.

The Age-Related Eye Disease Study Research Group. Design Paper, The age-related eye disease study (AREDS): design implications AREDS Report No. 1. Controlled Clinical Trials 20:573-600, 1999.

The Age-Related Eye Disease Study Research Group. The age-related eye disease study (AREDS): A clinical trial of Zinc and antioxidants, AREDS report No. 2. Journal of Nutrition, 130:1516S-1519S, 2000.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. Involution of Retinopathy of Prematurity. Arch Ophthalmology 118:645-649, 2000.

Eller AW, Mah FS, Friberg TR: Migration of silicone oil into the brain: a complication of silicone oil for retinal tamponade. Amer J Ophthalmol 129:685-688, 2000.

The Age-Related Eye Disease Study Research Group. Risk Factors Associated with Age-Related Macular Degeneration. A Case-control Study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 107:2224-2232, 2000.

Friberg TR, Eller AW: Laser pneumatic retinopexy for repair of recurrent retinal detachment after failed scleral buckle - Ten years experience. Ophthalmic Surgery and Lasers 32:13-18, 2001.

The Age-Related Eye Disease Study Research Group. AREDS Cataract Grading System. Age-Related Eye Disease Study Report Number 4. Amer J Ophthalmol 131:167-175, 2001.

Cooperative Group, Cryotherapy for Retinopathy of Prematurity. Does Cryotherapy Affect Refractive Error? Results from Treated versus Control Eyes in The Cryotherapy for Retinopathy of Prematurity Trial. Ophthalmology 108:343-347, 2001.

The Age-Related Eye Disease Study Research Group. Risk factors associated with age-related nuclear and cortical cataract: A case-control study in the Age-Related Eye Disease Study, AREDS Report Number 5. Ophthalmology 108:1400-1408, 2001.

The Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report Number 8. Arch Ophthalmol 119:1417-1436, 2001.

The Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, and beta carotene for age-related cataract and vision loss. AREDS Report Number 9. Arch Ophthalmol 119:1439-1452, 2001.

Weeks DE, Conley YP, Tsai HJ, Mah TS, Rosenfeld PJ, Paul TO, Eller AW, Morse LS, Dailey JP, Ferrell RE, and Gorin MB: Age-related maculopathy: An expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. Amer J Ophthalmol 132:682-692, 2001.
 
bullet point  Grants
a dividing bar
2000-Present
Co-Investigator,
A randomized, controlled study on the efficacy and safety of Sandostatin LAR in the therapy of patients with moderately severe or severe non-proliferative diabetic retinopathy (NPDR) or low risk proliferative diabetic retinopathy (PDR).
Total three-year budget $274,483. Novartis.

2000-Present
Use of a non-mydriatic panoramic imaging device.
Optos Corporation
$55,000.

1999-Present
Co-Investigator
A Phase III randomized, multi-center, double masked, placebo controlled parallel group study with Tin Ethyl Etiopuryltin photodynamic therapy in the treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration.
Miravant Medical Technologies, Estimated $100,000 x 3 years

1997-Present
Co-Investigator
Prophylactic Diode Laser Photocoagulation for the Prevention of Choroidal Neovascularization in Age-Related Macular Degeneration.
IRB No. 950505.
Eye and Ear Foundation of Pittsburgh, $50,000/year x 3 years.

1990-2004
Co-Investigator
Age Related Eye Disease Study.
National Eye Institute.
Multicenter clinical trial of vitamins and micronutrients on macular degeneration and cataract.
Contract number NIY-EY-89-01.
Direct costs $307,000/year x 10 years, 5 year extension granted.

1989-1995
Co-Investigator
Efficacy & Safety of Tolrestat (AY-27,773) in the Treatment of Diabetic Retinopathy in Non-Insulin Dependent (Type II) Diabetic Patients.
Protocol number 81-085-CR)
Wyeth-Ayerst Pharmaceutical
$90,000

1991
Co-Principal Investigator
Pittsburgh-Chernobyl Collaborative Study of Ophthalmic Complications in Ukranian Children - Funded by the Tri-State Committee of the Children's Chernobyl Relief Fund
$150,000.00 with non-monetary contributions by Kodak and Topcon
 
 
  Top of page  |  Home  |  Contact Us Last Update 3/22/2017  
  Office of the Senior Vice Chancellor for the Health Sciences, University of Pittsburgh. All rights reserved.